Commentary: Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome

Articolo
Data di Pubblicazione:
2021
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Brugada syndrome; CACNA1C; drug; L-type calcium channel; mutations; personalized medicine; pharmaceutical
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/120447
Pubblicato in:
FRONTIERS IN PHYSIOLOGY
Journal